NPI: 1124058615 · BRISTOL, TN 37620 · General Acute Care Hospital · NPI assigned 07/03/2006
Authorized official HILTON, SHANE controls 20+ related entities in our dataset. Read more
| Authorized Official | HILTON, SHANE (EVP/CFO) |
| NPI Enumeration Date | 07/03/2006 |
Other providers sharing the same authorized official: HILTON, SHANE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 72,913 | $2.86M |
| 2019 | 94,908 | $3.34M |
| 2020 | 78,573 | $3.44M |
| 2021 | 90,579 | $4.08M |
| 2022 | 88,415 | $4.28M |
| 2023 | 95,410 | $4.96M |
| 2024 | 72,204 | $4.38M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 42,726 | 37,393 | $8.49M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19,791 | 16,974 | $3.91M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,684 | 17,490 | $2.76M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,477 | 5,151 | $1.62M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,682 | 4,224 | $915K |
| 41899 | Unlisted procedure, dentoalveolar structures | 948 | 911 | $834K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,294 | 3,779 | $728K |
| G0378 | Hospital observation service, per hour | 5,741 | 3,672 | $605K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,953 | 4,479 | $504K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10,484 | 3,110 | $446K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,782 | 1,608 | $361K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,341 | 1,229 | $359K |
| 29581 | 2,487 | 737 | $340K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6,238 | 2,329 | $296K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,874 | 2,748 | $288K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 484 | 449 | $282K |
| 97602 | 1,538 | 503 | $275K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,813 | 1,576 | $231K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,889 | 2,111 | $228K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,161 | 3,798 | $221K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,071 | 1,485 | $206K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,487 | 2,449 | $205K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,474 | 3,825 | $195K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,236 | 1,138 | $192K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 544 | 501 | $140K |
| 59025 | Fetal non-stress test | 775 | 563 | $136K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,451 | 1,330 | $131K |
| 80053 | Comprehensive metabolic panel | 36,823 | 30,237 | $127K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,974 | 14,447 | $127K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,133 | 849 | $100K |
| 71046 | Radiologic examination, chest; 2 views | 11,273 | 9,935 | $100K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 538 | 485 | $99K |
| 97162 | 1,468 | 1,326 | $97K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 392 | 237 | $96K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 45,926 | 36,851 | $78K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 359 | 321 | $77K |
| 93017 | 774 | 712 | $75K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 261 | 243 | $74K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,778 | 1,683 | $74K |
| 78306 | 322 | 289 | $73K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,018 | 905 | $64K |
| 72141 | 345 | 328 | $60K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,272 | 9,338 | $52K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,217 | 2,071 | $51K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 563 | 500 | $50K |
| 97116 | 2,153 | 823 | $44K | |
| 93971 | 540 | 487 | $41K | |
| 72100 | 2,143 | 1,951 | $40K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 78 | 71 | $39K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14,812 | 12,148 | $37K |
| 49083 | 60 | 37 | $36K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 242 | 173 | $33K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 241 | 228 | $33K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 63 | 57 | $25K |
| 36415 | Collection of venous blood by venipuncture | 19,109 | 12,977 | $24K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2,548 | 2,113 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 134 | 128 | $23K |
| 83880 | 3,393 | 2,870 | $22K | |
| 71045 | Radiologic examination, chest; single view | 5,162 | 4,493 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | 960 | 876 | $20K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 449 | 409 | $19K |
| 84484 | 11,595 | 7,813 | $17K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 793 | 339 | $16K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 71 | 64 | $16K |
| 73562 | 1,483 | 1,297 | $15K | |
| 95813 | 31 | 30 | $14K | |
| 74018 | 1,473 | 1,315 | $13K | |
| 95816 | 66 | 64 | $13K | |
| 72131 | 272 | 241 | $12K | |
| 99215 | Prolong outpt/office vis | 54 | 40 | $12K |
| 87040 | 1,671 | 830 | $12K | |
| 76536 | 120 | 114 | $12K | |
| 81025 | 8,018 | 6,975 | $11K | |
| 76642 | 100 | 96 | $11K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 338 | 118 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,665 | 7,610 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,987 | 6,837 | $10K |
| 85027 | 6,036 | 4,984 | $9K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 12 | 12 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,525 | 2,301 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 52 | 50 | $8K |
| 29445 | 49 | 13 | $8K | |
| 73630 | 972 | 883 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 260 | 249 | $8K |
| 93923 | 83 | 78 | $8K | |
| 71250 | 102 | 96 | $8K | |
| 81001 | 17,007 | 14,508 | $7K | |
| 70496 | 28 | 24 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7,684 | 5,534 | $7K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,416 | 4,284 | $7K |
| 73030 | 841 | 744 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,350 | 10,717 | $7K |
| 90715 | 335 | 318 | $6K | |
| 72040 | 168 | 154 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,414 | 5,966 | $6K |
| 62323 | 32 | 26 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 97 | 92 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 493 | 439 | $5K |
| 76770 | 30 | 28 | $4K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 267 | 253 | $4K |
| 76830 | Ultrasound, transvaginal | 44 | 39 | $4K |
| 73130 | 661 | 599 | $4K | |
| 73502 | 384 | 350 | $4K | |
| 73610 | 740 | 651 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,602 | 5,927 | $4K |
| 80061 | Lipid panel | 947 | 884 | $4K |
| 85379 | 979 | 905 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 6,370 | 5,017 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 905 | 859 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | 1,028 | 480 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,242 | 1,756 | $3K |
| 72050 | 133 | 123 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,977 | 5,027 | $3K |
| 83690 | 7,954 | 6,776 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 16 | 13 | $3K |
| 77066 | Tomosynthesis, mammo | 58 | 52 | $3K |
| 77002 | 13 | 12 | $3K | |
| 83735 | 3,147 | 2,172 | $3K | |
| 97165 | 15 | 15 | $3K | |
| 77065 | Tomosynthesis, mammo | 60 | 54 | $2K |
| 72020 | 145 | 127 | $2K | |
| 12001 | 13 | 13 | $2K | |
| 81003 | 7,131 | 6,252 | $2K | |
| 96376 | 3,364 | 1,863 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,707 | 1,299 | $2K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 227 | 168 | $2K |
| 88307 | 130 | 102 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | 95 | 77 | $2K |
| 97166 | 15 | 14 | $2K | |
| 87205 | 134 | 124 | $2K | |
| 85652 | 1,044 | 905 | $2K | |
| 86140 | 441 | 383 | $2K | |
| 85610 | 2,200 | 1,783 | $2K | |
| 93880 | 33 | 29 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,235 | 5,638 | $2K |
| 76801 | 34 | 30 | $2K | |
| J3490 | Unclassified drugs | 4,066 | 1,612 | $1K |
| 83605 | 1,186 | 909 | $1K | |
| 77336 | 29 | 12 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 82 | 80 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 71 | 58 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,578 | 1,367 | $1K |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,787 | 1,634 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | 7,827 | 4,364 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,985 | 2,602 | $1K |
| 87536 | 14 | 13 | $1K | |
| 85730 | 753 | 675 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 409 | 356 | $1K |
| 71271 | 12 | 12 | $976.84 | |
| 82565 | 494 | 422 | $738.32 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 55 | 49 | $729.00 |
| 87081 | 1,106 | 1,016 | $681.17 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 14 | 12 | $680.61 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 304 | 194 | $640.52 |
| 73110 | 149 | 128 | $623.63 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 14 | 12 | $591.70 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,009 | 3,681 | $590.02 |
| 86901 | 1,095 | 916 | $589.40 | |
| 80076 | 180 | 164 | $573.73 | |
| 80143 | 128 | 111 | $545.60 | |
| 70486 | 13 | 12 | $522.08 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 930 | 883 | $513.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,323 | 2,238 | $503.07 |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14 | 12 | $487.95 |
| 84100 | 981 | 656 | $480.66 | |
| 70498 | 15 | 12 | $400.42 | |
| 87210 | 186 | 160 | $341.80 | |
| 85055 | 67 | 50 | $325.71 | |
| 80179 | 122 | 110 | $324.04 | |
| 82607 | 40 | 39 | $297.59 | |
| 72072 | 12 | 12 | $296.04 | |
| 87186 | 859 | 767 | $290.16 | |
| 86850 | 654 | 539 | $267.45 | |
| 84702 | 453 | 389 | $261.78 | |
| 80320 | 294 | 246 | $246.70 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 353 | 292 | $237.43 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 56 | 49 | $218.28 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,029 | 2,896 | $213.80 |
| J2785 | Injection, regadenoson, 0.1 mg | 215 | 201 | $199.26 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,129 | 1,025 | $182.15 |
| 86900 | 1,020 | 848 | $181.81 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,491 | 1,219 | $177.97 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 860 | 773 | $167.93 |
| 82570 | 110 | 92 | $162.74 | |
| 84439 | 62 | 58 | $160.68 | |
| 87077 | 837 | 743 | $159.92 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 437 | 318 | $141.09 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 19 | 19 | $137.45 |
| 84703 | 293 | 277 | $130.04 | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 484 | 344 | $108.47 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 498 | 463 | $107.92 |
| 87070 | 149 | 138 | $104.05 | |
| 82728 | 12 | 12 | $77.50 | |
| 94760 | 6,499 | 4,036 | $66.52 | |
| J1815 | Injection, insulin, per 5 units | 692 | 311 | $66.23 |
| 88304 | 140 | 129 | $49.68 | |
| A9270 | Non-covered item or service | 7,376 | 1,127 | $49.65 |
| 36600 | 31 | 24 | $48.14 | |
| 99152 | 151 | 134 | $36.04 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 586 | 493 | $34.78 |
| J1630 | Injection, haloperidol, up to 5 mg | 279 | 227 | $32.42 |
| J2060 | Injection, lorazepam, 2 mg | 284 | 199 | $25.57 |
| 82140 | 13 | 13 | $24.68 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 388 | 349 | $23.64 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 717 | 595 | $23.29 |
| 84156 | 34 | 25 | $22.43 | |
| 85007 | 32 | 25 | $20.96 | |
| 87807 | 256 | 237 | $19.63 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 280 | 204 | $18.79 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 150 | 98 | $18.32 |
| 73080 | 17 | 12 | $10.51 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 86 | 71 | $6.76 |
| 83615 | 14 | 12 | $5.05 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 20 | 13 | $1.79 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 13 | 13 | $1.76 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 151 | 63 | $1.45 |
| J1644 | Injection, heparin sodium, per 1000 units | 52 | 42 | $0.71 |
| J1940 | Injection, furosemide, up to 20 mg | 15 | 12 | $0.09 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 51 | 45 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 93 | 72 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 141 | 113 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 73 | 67 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 79 | 65 | $0.00 |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 81 | 77 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 49 | 38 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 92 | 72 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 122 | 81 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 26 | 12 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 43 | 38 | $0.00 |
| 76000 | 51 | 45 | $0.00 | |
| C1776 | Joint device (implantable) | 12 | 12 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 111 | 101 | $0.00 |
| C1769 | Guide wire | 258 | 232 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 4,184 | 3,018 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 491 | 403 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 53 | 26 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 26 | 24 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 52 | 41 | $0.00 |
| 94761 | 40 | 27 | $0.00 | |
| J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | 16 | 16 | $0.00 |
| 71101 | 28 | 25 | $0.00 | |
| 73090 | 29 | 25 | $0.00 |